Cardiovascular biomarkers and preeclampsia: A narrative review
Journal: European Journal of Clinical Investigation
Year: 2025

Cardiovascular biomarkers are becoming essential for diagnosing, monitoring and predicting outcomes in preeclampsia, enabling early detection and treatment. While some are already in clinical use, emerging biomarkers show promise for more precise and individualized care. Advancing research in this area offers significant potential to improve maternal and fetal outcomes.